Arno Therapeutics new buyers include Soros Fund Management, LLC, Chairman, Arie Belldegrun,MD (also chairman of Kite), OPKO Health, Inc.,Commercial Street Capital LLC, Pontifax, Bonderman Family Limited Partnership, Perceptive Advisors LLC and Auriga Capital Management. It trades at $.30. The company's drugs are in phase 2 of development.